Close

Novavax (NVAX) COVID-19 Vaccine Approval Delayed in India - Report

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. NFLX
4. CSX
5. SPY
6. UAL
7. ALK
8. EFX
9. TSLA
10. MU


Go back to Novavax (NVAX) COVID-19 Vaccine Approval Delayed in India - Report
Novavax, Inc. (NASDAQ: NVAX) Delayed: 3.89 --0 (-0%)
Previous Close $3.89    52 Week High $9.23 
Open $3.89    52 Week Low $1.16 
Day High $3.99    P/E N/A 
Day Low $3.81    EPS $-0.30 
Volume 2,861,577